Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 21-30 of 47

Page
per page
  1. AZD1480
    A4137 AZD1480
    Target: JAK
    Summary: JAK2 inhibitor,ATP-competitive and novel
      insoluble in H2O; ≥93.8 mg/mL
  2. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  3. Erlotinib Hydrochloride
    A8234 Erlotinib Hydrochloride
     2 Citation
    Summary: Selective EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥6.44 mg/mL
  4. SGI-1776 free base
    A4192 SGI-1776 free base
     3 Citation
    Summary: Pim kinase inhibitor,ATP-competitive
      ≥40.5 mg/mL
  5. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  6. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  7. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  8. RO8191
    C4533 RO8191
    Summary: IFN-α receptor 2 agonist
      ≤0.1 mg/mL
  9. TCS PIM-1 1
    A4521 TCS PIM-1 1
    Summary: Pim-1 kinase inhibitor,ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥12.8 mg/mL
  10. S-Ruxolitinib (INCB018424)
    A4149 S-Ruxolitinib (INCB018424)
    Target: JAK
    Summary: JAK1/2 inhibitor,potent and selective
      Soluble in DMSO

Items 21-30 of 47

Page
per page